Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, usually low grade chondrosarcoma characterized by the presence of tumor cells with clear cytoplasm. It usually arises in the epiphyseal ends of long bones.
Biomarker and diagnostic research for clear cell chondrosarcoma has been reported in the published literature.
2 clinical trials registered. Interventions under study include drug therapy, other interventions, and gene therapy. Pipeline includes 1 PHASE2, 1 NA. Research is primarily sponsored by academic and government institutions.
17 publications have been identified in PubMed for clear cell chondrosarcoma. Research spans Case Report / Case Series (47%), Epidemiology / Natural History (20%), and Diagnostic / Biomarker (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 9:38 PM UTC
Common questions about clear cell chondrosarcoma
Disease patterns and progression | 3 | 20% |
Testing and diagnosis research | 2 | 13% |
Research summaries | 2 | 13% |
New treatment approaches | 1 | 7% |
De Robertis M (2026). [PMID: 42112487](https://pubmed.ncbi.nlm.nih.gov/42112487/). *Front Surg*. [Case Report / Case Series]
Uppin SG (2026). [PMID: 41539257](https://pubmed.ncbi.nlm.nih.gov/41539257/). *Annals of diagnostic pathology*. [Diagnostic / Biomarker]
Remiszewski P (2026). [PMID: 41895355](https://pubmed.ncbi.nlm.nih.gov/41895355/). *Crit Rev Oncol Hematol*. [Review / Meta-Analysis]
Macarulla T (2026). [PMID: 41940135](https://pubmed.ncbi.nlm.nih.gov/41940135/). *EJC Suppl*. [Gene Therapy / Novel Therapeutics]
Patel LR (2026). [PMID: 42084452](https://pubmed.ncbi.nlm.nih.gov/42084452/). *Genes Chromosomes Cancer*. [Case Report / Case Series]
Pinto I (2025). [PMID: 41552210](https://pubmed.ncbi.nlm.nih.gov/41552210/). *Cureus*. [Diagnostic / Biomarker]
Kobayashi H (2025). [PMID: 41173044](https://pubmed.ncbi.nlm.nih.gov/41173044/). *The bone & joint journal*. [Case Report / Case Series]
Zheng X (2025). [PMID: 40346788](https://pubmed.ncbi.nlm.nih.gov/40346788/). *Journal of orthopaedic surgery (Hong Kong)*. [Epidemiology / Natural History]
Boudou-Rouquette P (2025). [PMID: 40140320](https://pubmed.ncbi.nlm.nih.gov/40140320/). *Bulletin du cancer*. [Epidemiology / Natural History]
Cheung IHW (2024). [PMID: 39280730](https://pubmed.ncbi.nlm.nih.gov/39280730/). *Radiology case reports*. [Case Report / Case Series]
AI-curated news mentioning clear cell chondrosarcoma
Updated May 1, 2026
A case report highlights the genomic and transcriptomic analysis of clear cell chondrosarcoma with somatic VHL inactivation. This study provides insights into the molecular underpinnings of this rare tumor type.